首页> 美国卫生研究院文献>Sensors (Basel Switzerland) >Simultaneous Detection of α-Fetoprotein and Carcinoembryonic Antigen Based on Si Nanowire Field-Effect Transistors
【2h】

Simultaneous Detection of α-Fetoprotein and Carcinoembryonic Antigen Based on Si Nanowire Field-Effect Transistors

机译:基于硅纳米线场效应晶体管的α-甲胎蛋白和癌胚抗原的同时检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Primary hepatic carcinoma (PHC) is one of the most common malignancies worldwide, resulting in death within six to 20 months. The survival rate can be improved by effective treatments when diagnosed at an early stage. The α-fetoprotein (AFP) and carcinoembryonic antigen (CEA) have been identified as markers that are expressed at higher levels in PHC patients. In this study, we employed silicon nanowire field-effect transistors (SiNW-FETs) with polydimethylsiloxane (PDMS) microfluidic channels to simultaneously detect AFP and CEA in desalted human serum. Dual-channel PDMS was first utilized for the selective modification of AFP and CEA antibodies on SiNWs, while single-channel PDMS offers faster and more sensitive detection of AFP and CEA in serum. During the SiNW modification process, 0.1% BSA was utilized to minimize nonspecific protein binding from serum. The linear dynamic ranges for the AFP and CEA detection were measured to be 500 fg/mL to 50 ng/mL and 50 fg/mL to 10 ng/mL, respectively. Our work demonstrates the promising potential of fabricated SiNW-FETs as a direct detection kit for multiple tumor markers in serum; therefore, it provides a chance for early stage diagnose and, hence, more effective treatments for PHC patients.
机译:原发性肝癌(PHC)是全球最常见的恶性肿瘤之一,导致6至20个月内死亡。如果在早期诊断出有效的治疗方法,可以提高生存率。已确认α-甲胎蛋白(AFP)和癌胚抗原(CEA)是在PHC患者中以较高水平表达的标志物。在这项研究中,我们采用了具有聚二甲基硅氧烷(PDMS)微流体通道的硅纳米线场效应晶体管(SiNW-FET),以同时检测脱盐人体血清中的AFP和CEA。双通道PDMS首先用于选择性修饰SiNWs上的AFP和CEA抗体,而单通道PDMS提供更快,更灵敏的血清中AFP和CEA检测。在SiNW修饰过程中,使用0.1%BSA可以最大程度地减少血清中非特异性蛋白的结合。 AFP和CEA检测的线性动态范围分别为500 fg / mL至50 ng / mL和50 fg / mL至10 ng / mL。我们的工作证明了制造的SiNW-FET作为血清中多种肿瘤标志物的直接检测试剂盒的潜力。因此,它为早期诊断提供了机会,从而为PHC患者提供了更有效的治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号